# JOHNS HOPKINS UNIVERSITY: Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP)

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | JOHNS HOPKINS UNIVERSITY |
| Location | BALTIMORE, MD |
| Project | Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP) |
| Project number | 3R00HL172303-03S1 |
| Mechanism | R00 |
| Institute | National Heart Lung and Blood Institute |
| Award | $108,850 |
| Awarded | 2026-09-17 |
| Project period | 2024-08-27 to 2027-07-31 |
| UEI | FTMTDMBR29C7 |

## Why this score
- Award of $108,850.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11638596). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.